6-46688561-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001010870.3(TDRD6):c.433G>A(p.Glu145Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000977 in 1,586,450 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001010870.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TDRD6 | NM_001010870.3 | c.433G>A | p.Glu145Lys | missense_variant | 1/4 | ENST00000316081.11 | NP_001010870.1 | |
TDRD6 | NM_001168359.2 | c.433G>A | p.Glu145Lys | missense_variant | 1/3 | NP_001161831.1 | ||
TDRD6 | NR_144468.2 | n.1372+6922G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TDRD6 | ENST00000316081.11 | c.433G>A | p.Glu145Lys | missense_variant | 1/4 | 1 | NM_001010870.3 | ENSP00000346065.5 | ||
TDRD6 | ENST00000544460.5 | c.433G>A | p.Glu145Lys | missense_variant | 1/3 | 2 | ENSP00000443299.1 |
Frequencies
GnomAD3 genomes AF: 0.000572 AC: 87AN: 152142Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000118 AC: 24AN: 203634Hom.: 0 AF XY: 0.0000792 AC XY: 9AN XY: 113696
GnomAD4 exome AF: 0.0000467 AC: 67AN: 1434198Hom.: 0 Cov.: 30 AF XY: 0.0000421 AC XY: 30AN XY: 712798
GnomAD4 genome AF: 0.000578 AC: 88AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.000537 AC XY: 40AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 07, 2024 | The c.433G>A (p.E145K) alteration is located in exon 1 (coding exon 1) of the TDRD6 gene. This alteration results from a G to A substitution at nucleotide position 433, causing the glutamic acid (E) at amino acid position 145 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at